PGD template for Shingrix® vaccine for immunocompromised individuals. Category: UncategorisedBy 31 August 2021Leave a commentPost navigationPreviousPrevious post:Guidance: COVID-19: guidance for households with possible coronavirus infectionNextNext post:Guidance: Shingles vaccine (Zostavax®): patient group direction (PGD) template